648. Urinary tract-associated Escherichia coli bacteraemia strains are genetically more virulent than those originating from non-urinary and neutropaenic infective foci.
Session: Poster Abstract Session: Pathogenesis and Immune Response
Thursday, October 4, 2018
Room: S Poster Hall
  • E. coli poster, IDWeek 2018 V3.0 20.09.18.pdf (1.1 MB)
  • Background:

    Escherichia coli is the leading cause of bacteraemia with multi-drug-resistant strains proving increasingly problematic. Knowledge of the strain diversity associated with site-specific infections will inform the development of new preventative strategies, e.g. vaccines. We hypothesised that virulence factor (VF) scores of bacteraemia strains from neutropaenic patients with unknown infective foci (NPUIF - likely due to bowel translocation) would be lower than those from immunocompetent patients.


    Immunocompetent (n=49) and neutropaenic adults (n=8) with E. coli bacteraemia were prospectively enrolled and the focus of bacteraemia determined. Neutropaenic patients were enrolled only if there was no identifiable infective focus. Multi-locus sequence typing and VF score (31 known VFs included) data were derived in silico following whole genome sequencing and the results compared between patient groups.


    Bacteraemia strains from immunocompetent patients with urinary tract infective foci (UTI-foci) harboured significantly more VFs (median VF score 16, range 8-24) than strains from both immunocompetent patients with non-UTI-foci (10, 2-22, p=0.006) and NPUIF (8, 3-13, p<0.0001). VF scores of strains from non-UTI-foci were not significantly different to those from NPUIF (10, 2-22 vs 8, 3-13, respectively. p=0.28). Logistic regression analysis demonstrated that VF score (OR 1.21, 95% CIs 1.01-1.46, p=0.039) and recurrent urinary tract infection/urinary tract infection (OR 12.82, 95% CIs 1.24-132.65, p=0.032) were independent predictors of bacteraemia secondary to UTI-foci vs. non-UTI-foci in immunocompetent patients. Hence, for every unit increase in VF score, the odds of a bacteraemia strain originating from UTI-foci increased by 1.21. papA, papC, papE/F, papG, agn43, tia, iut, fyuA, kpsM and sat were significantly more prevalent amongst strains associated with UTI-foci vs non-UTI-foci amongst immunocompetent patients. papC, papE/F, papG, agn43, tia, fyuA, hlyA, usp and clb were significantly more prevalent amongst UTI-foci- vs NPUIF-associated strains.

    Conclusion: UTI-associated E. coli bacteraemia strains have distinct VF profiles from those originating from non-UTI-foci and NPUIF. Future vaccines must consider this diversity to ensure adequate coverage of strains associated with site-specific disease.

    Adam Dale, MBChB, BSc, MRCP, FRCPath1, Anish Pandey, PhD1, Richard Hesp, PhD2, Konstantinos Belogiannis, MD1, Jay Laver, PhD1, Clifford Shone, PhD2 and Robert Read, MD, FIDSA3, (1)Academic Unit of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom, (2)Public Health England, Public Health England, Salisbury, United Kingdom, (3)Faculty of Medicine and Institute of Life Science, University of Southampton and Nihr Biomedical Research Centre, University of Southampton, Southampton, United Kingdom


    A. Dale, None

    A. Pandey, None

    R. Hesp, None

    K. Belogiannis, None

    J. Laver, None

    C. Shone, None

    R. Read, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.